Curocell큐로셀
372320 · KOSDAQ · ₩372320 · 큐로셀
₩24,400▲ ₩1,100 (4.72%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | ₩0 | ₩0 | ₩0 |
| Cost of sales | ₩0 | ₩0 | ₩0 |
| Gross profit | ₩0 | ₩0 | ₩0 |
| Operating income | −₩36B | −₩37B | −₩31B |
| Net income | −₩46B | −₩38B | −₩30B |
| Net income to shareholders | −₩46B | −₩38B | −₩30B |
Balance sheet
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total assets | ₩110B | ₩72B | ₩105B |
| Current assets | ₩32B | ₩13B | ₩43B |
| Cash and equivalents | ₩10B | ₩4.6B | ₩9.9B |
| Total liabilities | ₩105B | ₩43B | ₩46B |
| Current liabilities | ₩97B | ₩39B | ₩3.3B |
| Borrowings | ₩55B | ₩35B | ₩40B |
| Total equity | ₩5B | ₩29B | ₩59B |
| Shareholders' equity | ₩5B | ₩29B | ₩59B |
Cash flow
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash from operations | −₩30B | −₩28B | −₩25B |
| Capital spending | ₩313M | ₩441M | −₩21B |
| Free cash flow | −₩30B | −₩29B | −₩46B |
Consolidated where available. Amounts in won.
Also known as: Curocell / 큐로셀 / 372320 / KRX:372320
Source: KRX statistical information